JCR Pharmaceuticals Faces Declining Profits

JCR Pharmaceuticals Co., Ltd. (JP:4552) has released an update.

JCR Pharmaceuticals Co., Ltd. has reported a significant decline in their quarterly financial performance, with a 24.6% decrease in net sales and a sharp fall in profits attributable to owners by 87.5% compared to the previous year. The company’s total assets marginally increased, while net assets saw a slight decrease, resulting in a 1.8% drop in capital adequacy ratio. Despite these challenges, JCR Pharmaceuticals maintains a robust capital adequacy ratio of 52.4%.

For further insights into JP:4552 stock, check out TipRanks’ Stock Analysis page.